Prime Medicine, Inc.·4

Mar 3, 8:16 PM ET

Goldwasser Meredith 4

4 · Prime Medicine, Inc. · Filed Mar 3, 2025

Insider Transaction Report

Form 4
Period: 2025-02-27
Goldwasser Meredith
SVP, Strategy & Corporate Ops.
Transactions
  • Award

    Stock Option (right to buy)

    2025-02-27+90,50090,500 total
    Exercise: $2.42Exp: 2035-02-27Common Stock (90,500 underlying)
Footnotes (1)
  • [F1]1/48th of the shares underlying this option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of February 27, 2025, subject to the Reporting Person's continued service on each such vesting date.

Documents

1 file
  • 4
    wk-form4_1741051009.xmlPrimary

    FORM 4